IBDEI0SM ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13166,0)
 ;;=H40.63X2^^80^754^31
 ;;^UTILITY(U,$J,358.3,13166,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13166,1,3,0)
 ;;=3^Drug-Induced Glaucoma,Bilateral,Moderate Stage
 ;;^UTILITY(U,$J,358.3,13166,1,4,0)
 ;;=4^H40.63X2
 ;;^UTILITY(U,$J,358.3,13166,2)
 ;;=^5005916
 ;;^UTILITY(U,$J,358.3,13167,0)
 ;;=H40.63X3^^80^754^32
 ;;^UTILITY(U,$J,358.3,13167,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13167,1,3,0)
 ;;=3^Drug-Induced Glaucoma,Bilateral,Severe Stage
 ;;^UTILITY(U,$J,358.3,13167,1,4,0)
 ;;=4^H40.63X3
 ;;^UTILITY(U,$J,358.3,13167,2)
 ;;=^5005917
 ;;^UTILITY(U,$J,358.3,13168,0)
 ;;=H40.63X4^^80^754^29
 ;;^UTILITY(U,$J,358.3,13168,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13168,1,3,0)
 ;;=3^Drug-Induced Glaucoma,Bilateral,Indeterminate Stage
 ;;^UTILITY(U,$J,358.3,13168,1,4,0)
 ;;=4^H40.63X4
 ;;^UTILITY(U,$J,358.3,13168,2)
 ;;=^5005918
 ;;^UTILITY(U,$J,358.3,13169,0)
 ;;=H40.51X0^^80^754^54
 ;;^UTILITY(U,$J,358.3,13169,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13169,1,3,0)
 ;;=3^Glaucoma Sec to Oth Eye Disorder,Right Eye,Unspec Stage
 ;;^UTILITY(U,$J,358.3,13169,1,4,0)
 ;;=4^H40.51X0
 ;;^UTILITY(U,$J,358.3,13169,2)
 ;;=^5005888
 ;;^UTILITY(U,$J,358.3,13170,0)
 ;;=H40.51X1^^80^754^55
 ;;^UTILITY(U,$J,358.3,13170,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13170,1,3,0)
 ;;=3^Glaucoma Sec to Oth Eye Disorder,Right Eye,Mild Stage
 ;;^UTILITY(U,$J,358.3,13170,1,4,0)
 ;;=4^H40.51X1
 ;;^UTILITY(U,$J,358.3,13170,2)
 ;;=^5005889
 ;;^UTILITY(U,$J,358.3,13171,0)
 ;;=H40.51X2^^80^754^56
 ;;^UTILITY(U,$J,358.3,13171,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13171,1,3,0)
 ;;=3^Glaucoma Sec to Oth Eye Disorder,Right Eye,Moderate Stage
 ;;^UTILITY(U,$J,358.3,13171,1,4,0)
 ;;=4^H40.51X2
 ;;^UTILITY(U,$J,358.3,13171,2)
 ;;=^5005890
 ;;^UTILITY(U,$J,358.3,13172,0)
 ;;=H40.51X3^^80^754^57
 ;;^UTILITY(U,$J,358.3,13172,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13172,1,3,0)
 ;;=3^Glaucoma Sec to Oth Eye Disorder,Right Eye,Severe Stage
 ;;^UTILITY(U,$J,358.3,13172,1,4,0)
 ;;=4^H40.51X3
 ;;^UTILITY(U,$J,358.3,13172,2)
 ;;=^5133507
 ;;^UTILITY(U,$J,358.3,13173,0)
 ;;=H40.51X4^^80^754^58
 ;;^UTILITY(U,$J,358.3,13173,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13173,1,3,0)
 ;;=3^Glaucoma Sec to Oth Eye Disorder,Right Eye,Indeterminate Stage
 ;;^UTILITY(U,$J,358.3,13173,1,4,0)
 ;;=4^H40.51X4
 ;;^UTILITY(U,$J,358.3,13173,2)
 ;;=^5005891
 ;;^UTILITY(U,$J,358.3,13174,0)
 ;;=H40.52X0^^80^754^49
 ;;^UTILITY(U,$J,358.3,13174,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13174,1,3,0)
 ;;=3^Glaucoma Sec to Oth Eye Disorder,Left Eye,Unspec Stage
 ;;^UTILITY(U,$J,358.3,13174,1,4,0)
 ;;=4^H40.52X0
 ;;^UTILITY(U,$J,358.3,13174,2)
 ;;=^5005892
 ;;^UTILITY(U,$J,358.3,13175,0)
 ;;=H40.52X1^^80^754^50
 ;;^UTILITY(U,$J,358.3,13175,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13175,1,3,0)
 ;;=3^Glaucoma Sec to Oth Eye Disorder,Left Eye,Mild Stage
 ;;^UTILITY(U,$J,358.3,13175,1,4,0)
 ;;=4^H40.52X1
 ;;^UTILITY(U,$J,358.3,13175,2)
 ;;=^5005893
 ;;^UTILITY(U,$J,358.3,13176,0)
 ;;=H40.52X2^^80^754^51
 ;;^UTILITY(U,$J,358.3,13176,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13176,1,3,0)
 ;;=3^Glaucoma Sec to Oth Eye Disorder,Left Eye,Moderate Stage
 ;;^UTILITY(U,$J,358.3,13176,1,4,0)
 ;;=4^H40.52X2
 ;;^UTILITY(U,$J,358.3,13176,2)
 ;;=^5005894
 ;;^UTILITY(U,$J,358.3,13177,0)
 ;;=H40.52X3^^80^754^52
 ;;^UTILITY(U,$J,358.3,13177,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13177,1,3,0)
 ;;=3^Glaucoma Sec to Oth Eye Disorder,Left Eye,Severe Stage
 ;;^UTILITY(U,$J,358.3,13177,1,4,0)
 ;;=4^H40.52X3
